Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

From experimental units to unique experiments: chronobiologic pilots complement large trials.

F Halberg1, G Cornélissen, C Bingham

  • 1Chronobiology Laboratories, University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis 55455.

In Vivo (Athens, Greece)
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of two long acting pre-lambing anthelmintic treatments on the productivity of ewes in low body condition.

New Zealand veterinary journal·2016
Same author

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

The New England journal of medicine·2013
Same author

Cugini's syndrome in statu nascendi. Oratio contra morem prevalentem et pro chronobiologica ratione ad pressione sanguinis curandam. A plea against the prevailing custom and in favor of a chronobiological approach to treating blood pressure.

La Clinica terapeutica·2009
Same author

Tools to evaluate estrogenic potency of dietary phytoestrogens:A consensus paper from the EU Thematic Network "Phytohealth" (QLKI-2002-2453).

Genes & nutrition·2008
Same author

Low prevalence of mitochondrial DNA 3243A>G point mutation in Caucasians with unexplained renal disease.

Diabetic medicine : a journal of the British Diabetic Association·2007
Same author

Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development.

Diabetic medicine : a journal of the British Diabetic Association·2006
Same journal

Time-Dependent Inflammatory Cytokine Responses in a Human Fetal Membrane Dual-Compartment Model.

In vivo (Athens, Greece)·2026
Same journal

Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study.

In vivo (Athens, Greece)·2026
Same journal

Nutritional Support for Treatment Continuity and Survival in Advanced Gastric Cancer: A Propensity Score-matched Study.

In vivo (Athens, Greece)·2026
Same journal

Efficacy of Switching from Prior Nonsteroidal Anti-inflammatory Drugs to Transdermal Diclofenac in Cancer Pain Management.

In vivo (Athens, Greece)·2026
Same journal

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>.

In vivo (Athens, Greece)·2026
Same journal

Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.

In vivo (Athens, Greece)·2026
See all related articles

Optimizing chronochemotherapy requires detailed individual rhythm mapping. This approach uses extensive single-subject data to establish personalized treatment timing, improving outcomes for large patient groups.

Area of Science:

  • Chronobiology
  • Pharmacology
  • Medical Statistics

Background:

  • Treatment timing significantly impacts therapeutic outcomes.
  • Current research often lacks sufficient data on individual biological rhythms for personalized medicine.

Purpose of the Study:

  • To optimize chronochemotherapy by mapping multi-frequency rhythm spectra.
  • To establish cost-effective methods for gathering chronobiologic data for clinical trials.

Main Methods:

  • Extensive marker determinations (1000) on single subjects to map rhythm spectra.
  • Utilizing N-of-6 subgroups with staggered sampling (60 units apart).
  • Employing sequential tests, marker rhythmometry, and cosinor analysis.

Main Results:

Related Experiment Videos

  • Individualized rhythm mapping provides more informative data than population-based sampling.
  • N-of-6 designs allow for detailed mapping of biological time structures.
  • Minimal sampling requirements can be determined after mapping.

Conclusions:

  • Chronobiologic N-of-1 and N-of-6 pilot designs are cost-effective precursors to large randomized controlled trials.
  • Personalized treatment timing derived from rhythmometry can be translated to benefit patient populations.
  • Advanced statistical tools enable extraction of otherwise unattainable data for patient benefit.